Related Experiment Videos

Effect of probucol on mRNA expression of glomerular antioxidant enzymes in rat with subtotal nephrectomy

Z Tang1, D Ji, L Li

  • 1Department of Nephrology, Jinling Hospital, School of Medicine, Nanjing University.

Chinese Medical Journal
|October 1, 1996
PubMed
Abstract

Insights

Glomerular antioxidant enzymes (AOEs) are deficient in chronic kidney disease, contributing to injury. Probucol treatment improved renal function and reduced glomerulosclerosis by enhancing AOEs.

Area of Science:

  • Nephrology
  • Biochemistry
  • Pharmacology

Background:

  • Chronic kidney disease is associated with oxidative stress and impaired antioxidant defenses.
  • Glomerular antioxidant enzymes (AOEs) play a crucial role in protecting the kidney from oxidative damage.
  • Subtotal nephrectomy in rats is a model for studying chronic kidney disease progression.

Purpose of the Study:

  • To investigate glomerular antioxidant enzyme (AOE) mRNA expression and protein activity, including superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels in subtotal nephrectomized rats.
  • To evaluate the effects of probucol, a potent antioxidant, on these parameters in the chronic phase of kidney injury.

Main Methods:

  • Adult male Sprague-Dawley rats underwent 5/6 subtotal nephrectomy or sham surgery.
  • Rats were divided into nephrectomized (5/6 Nx) and nephrectomized plus probucol (5/6 Nx+P) groups.
  • Glomerular MDA content, SOD and GSH-Px activity, and AOE mRNA expression were analyzed at 12 weeks.

Main Results:

  • Subtotal nephrectomy led to increased serum cholesterol, proteinuria, and glomerulosclerosis index (GI), with decreased creatinine clearance.
  • Probucol treatment significantly ameliorated these abnormalities, reducing GI and improving renal function.
  • Probucol therapy also improved the decrease in glomerular Mn-SOD and GSH-Px (mRNA and activity) and the increase in MDA content.

Conclusions:

  • A deficiency in glomerular antioxidant enzymes (AOEs) occurs in the chronic phase of remnant kidney disease, potentially driving renal injury progression.
  • Probucol demonstrates protective effects against renal functional impairment and glomerulosclerosis development.
  • These protective effects may be partly attributed to the improvement of glomerular AOE levels by probucol.

Related Concept Videos